These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 19469265

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV, Gross JL, Camargo JL, Zelmanovitz T, da Costa Rocha EP, Azevedo MJ.
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA, Abdella N, George S.
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and determinants of microalbuminurea among type 2 diabetes mellitus patients, Baghdad, Iraq, 2013.
    Ali AA, Al Lami FH.
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):348-55. PubMed ID: 26997390
    [Abstract] [Full Text] [Related]

  • 5. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I, Covarsí A, Novillo R, Gómez-Martino JR, Ferrando L.
    Nefrologia; 2002 Mar; 22(2):162-9. PubMed ID: 12085417
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.
    Zhonghua Yi Xue Za Zhi; 2013 Apr 09; 93(14):1067-71. PubMed ID: 23902838
    [Abstract] [Full Text] [Related]

  • 8. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.
    Kramer HJ, Nguyen QD, Curhan G, Hsu CY.
    JAMA; 2003 Jun 25; 289(24):3273-7. PubMed ID: 12824208
    [Abstract] [Full Text] [Related]

  • 9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 25; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus.
    Krairittichai U, Potisat S, Jongsareejit A, Sattaputh C.
    J Med Assoc Thai; 2011 Mar 25; 94 Suppl 2():S1-5. PubMed ID: 21717870
    [Abstract] [Full Text] [Related]

  • 11. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV, Koshel' LV, Vagodin VA, Dedov II.
    Ter Arkh; 2006 Mar 25; 78(5):60-4. PubMed ID: 16889052
    [Abstract] [Full Text] [Related]

  • 12. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy.
    Ngarmukos C, Bunnag P, Kosachunhanun N, Krittiyawong S, Leelawatana R, Prathipanawatr T, Plengvidhya N, Benjasuratwong Y, Suwanwalaikorn S, Deerochanawong C, Chetthakul T, Mongkolsomlit S, Rawdaree P.
    J Med Assoc Thai; 2006 Aug 25; 89 Suppl 1():S37-42. PubMed ID: 17715832
    [Abstract] [Full Text] [Related]

  • 13. Non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus.
    Lee EY, Chung CH, Choi SO.
    Yonsei Med J; 1999 Aug 25; 40(4):321-6. PubMed ID: 10487133
    [Abstract] [Full Text] [Related]

  • 14. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.
    Diabetes Metab Res Rev; 2009 Mar 25; 25(3):232-41. PubMed ID: 19177462
    [Abstract] [Full Text] [Related]

  • 15. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Mar 25; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 16. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes.
    Canani LH, Costa LA, Crispim D, Gonçalves Dos Santos K, Roisenberg I, Lisbôa HR, Sarturi Tres G, Maia AL, Gross JL.
    Diabet Med; 2005 Sep 25; 22(9):1167-72. PubMed ID: 16108844
    [Abstract] [Full Text] [Related]

  • 17. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC, Collaborative Study Group.
    Nephrology (Carlton); 2013 Jul 25; 18(7):516-24. PubMed ID: 23506627
    [Abstract] [Full Text] [Related]

  • 18. Blood pressure by 24 h ambulatory recordings in type 2 (non-insulin dependent) diabetics. Relationship to urinary albumin excretion.
    Schmitz A, Pedersen MM, Hansen KW.
    Diabete Metab; 1991 Jul 25; 17(2):301-7. PubMed ID: 1864438
    [Abstract] [Full Text] [Related]

  • 19. The relationship between diabetic retinopathy and diabetic nephropathy in a population-based study in Korea (KNHANES V-2, 3).
    Lee WJ, Sobrin L, Lee MJ, Kang MH, Seong M, Cho H.
    Invest Ophthalmol Vis Sci; 2014 Sep 09; 55(10):6547-53. PubMed ID: 25205863
    [Abstract] [Full Text] [Related]

  • 20. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
    Shikata K, Haneda M, Koya D, Suzuki Y, Tomino Y, Yamada K, Maeda S, Kawakami N, Uzu T, Nishimura M, Sato C, Ogawa D, Makino H, DNETT-Japan Study Group.
    Diabetes Res Clin Pract; 2010 Feb 09; 87(2):228-32. PubMed ID: 19889469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.